| Literature DB >> 32917952 |
Keigo Takeshima1,2, Koji Tanaka3, Ryusaburo Mori3, Yu Wakatsuki3, Hajime Onoe3, Takuya Sakakibara3, Yorihisa Kitagawa3, Hiroyuki Nakashizuka3, Norihiro Tsuchiya3,4.
Abstract
The purpose of this study was to quantitatively analyze heart rate variability (HRV) in patients with central serous chorioretinopathy (CSC) by using a smartphone-based application (ANBAI: DUMSCO Inc.) for measurement, and to clarify its relationships with CSC. The subjects were 64 CSC patients (mean age 48.7 ± 7.6 years, 57 males and 7 females). After providing consent, the patients downloaded ANBAI apps to their smartphones. HRV was measured by photoelectric volume pulse wave measurement with a smartphone camera each morning for a minimum of 1 week. The primary outcome was to analyze HRV by calculating log LF/HF (Low Frequency/High Frequency components), an index of autonomic tone, which was then compared with a control group of 35,226 individuals from the application. Secondary outcome measures included disease duration, body mass index, exercise habits, smoking history, steroid use, occupation, lifestyle regularity, psychological fatigue, physical fatigue, and average sleep time. The log LF/HF was significantly higher in the patient group than in the control group (P < 0.001). Log LF/HF was significantly lower in patients with exercise habits as a factor contributing to log LF/HF in the patient group (P = 0.019). Analysis of HRV in CSC patients showed an impairment of the autonomic nervous system. Exercise habits may also be associated with CSC.Entities:
Mesh:
Year: 2020 PMID: 32917952 PMCID: PMC7486920 DOI: 10.1038/s41598-020-71938-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Heart rate variability waveform. This figure shows data for heart rate variability time recorded over a 300 s period under resting conditions in a healthy individual. Units on the horizontal axis are times (s) and units on the vertical axis are heart rate intervals (ms).
Figure 2Power spectral density and spectral components. LF (Low Frequency) is represented by the red area, and HF (High Frequency) by the blue area. To measure the areas of the HF and LF components, the LF component region of the power spectrum (0.05 Hz to 0.15 Hz) and the intensity of the HF component region (0.15 Hz to 0.40 Hz) are combined.
Figure 3How to measure heart rate variability with a smartphone. The smartphone application (ANBAI: DUMSCO, Inc.) uses the camera (CMOS; complementary metal-oxide semiconductor) attached to the smartphone as a light receptor and the LED (Light Emitting Diode) flashlight as a light source to make the smartphone an optical electric volume pulse wave measuring device, and the data thus obtained can be used to perform heart rate variability analysis.
Characteristics of patients. Values are presented as the mean ± standard deviation.
| Age (year) | 48.7 ± 7.6 |
| Refraction (Diopter) | − 1.35 ± 3.5 |
| Disease duration (months) | 20.0 ± 24.6 |
| BMI | 23.47 ± 2.72 |
| CRT (μm) | 357.4 ± 135.1 |
| CCT (μm) | 423.8 ± 112.5 |
| ETDRS visual acuity (letters) | 81.1 ± 10.4 |
BMI Body mass index, CRT central retinal thickness, CCT central choroidal thickness, ETDRS Early Treatment of Diabetic Retinopathy Study.
Comparison of log LF/HF between patients and controls.
| Control | Patients | ||
|---|---|---|---|
| EMM ± SD | EMM ± SD | ||
| log LF/HF | 0.22 ± 0.01 | 0.34 ± 0.03 | < 0.0001* |
EMM estimated marginal mean, LF/HF low frequency/high frequency, SD standard deviation.
*P value < 0.05.
Associations between log LF/HF and the background factors of CSC patients.
| Mean | Relation to log LF/HF | ||
|---|---|---|---|
| ρ | |||
| Age (years) | 48.7 ± 7.6 | − 0.054 | 0.671 |
| Sex (male:female) | 57:7 | − 0.215 | 0.087 |
| Disease duration (months) | 20.0 ± 24.6 | 0.017 | 0.895 |
| BMI | 23.47 ± 2.72 | 0.067 | 0.599 |
| Exercise habitsa | 45% | 0.293 | 0.019* |
| Smoking (current) | 27% | 0.156 | 0.218 |
| Steroids (in use) | 19% | 0.067 | 0.598 |
| Job (%) | |||
| Clerical | 58% | 0.302 | 0.793 |
| Outdoors | 28% | 0.229 | 0.307 |
| Driver | 11% | 0.544 | 0.059 |
| Other | 3% | 0.359 | 0.970 |
| Well-regulated life | 36% | − 0.043 | 0.735 |
| Psychological fatigue | 2.07 ± 0.60 | 0.163 | 0.199 |
| Physical fatigue | 2.16 ± 0.61 | 0.200 | 0.112 |
| Sleeping time (/day) | 6.17 ± 0.59 | − 0.008 | 0.948 |
| CRT (μm) | 357.4 ± 135.1 | − 0.200 | 0.113 |
| CCT (μm) | 423.8 ± 112.5 | − 0.180 | 0.155 |
| ETDRS visual acuity (letters) | 81.1 ± 10.4 | − 0.087 | 0.497 |
aExercise habits in the patient group (do you exercise more than 30 min twice a week?
(1: yes, 2: no), current smoking (1: yes, 2: no), inhalant and oral steroid use (1: yes, 2: no), Job (1: clerical, 2: outdoors (construction site, farming, etc.), 3: driver (taxi, bus, train driver), 4: other), well-regulated life (1: yes, 2: no), psychological fatigue (1: no, 2: minimal, 3: yes,) physical fatigue (1: no, 2: minimal, 3: yes), and mean sleeping times were collected by interview.
BMI Body mass index, CSC central serous chorioretinopathy, CRT central retinal thickness, CCT central choroidal thickness, ETDRS Early Treatment of Diabetic Retinopathy Study, log LF/HF Low Frequency/High Frequency, ρ Spearman's rank correlation coefficient.
*P value < 0.05.
Comparison of log LF/HF between acute and chronic CSC.
| Acute CSC (n = 24) | Chronic CSC (n = 40) | ||
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| log LF/HF | 0.48 ± 0.78 | 0.54 ± 0.59 | 0.728 |
Acute CSC within 3 months of onset, Chronic CSC more than 3 months after onset, CSC central serous chorioretinopathy; LF/HF low frequency/high frequency, SD standard deviation.
*P value < 0.05.